Johnson & Johnson today announced promising new results from the Phase 1b/2 OrigAMI-4 study evaluating the efficacy and safety of subcutaneous (SC) amivantamab monotherapy in patients with human ...

SystImmune Inc. (SystImmune), a clinical-stage biotechnology company, today announced positive topline results from the ...

State emergency management officials say they're facing funding challenges from the federal government that threaten the ...

A week of fractious back-and-forth between the U.S. and China drove the point home as Trump responded to new export controls ...

Readers respond to writer Thomas Keneally’s argument that at 90 years of age he’s had it with Australia not being a republic.

Thousands showed up to protest Donald Trump’s administration across the country on Saturday, with several taking place in the ...

Liverpool took in 63 games during the 2021-22 campaign, gracing every fixture available to them, and will want to come back into contention for more major honours at home and abroad when another ...

Unlike the older generation, young professionals are investing in digital gold this Diwali season. Traditionally, Dhanteras ...

AI chipmaker Nvidia ($NVDA) continues to attract strong optimism from both investors and analysts, fueled by its dominant ...